Fundraising Fox

Biodesix

NASDAQ: BDSX

Boulder, US · Delaware corporation

Biotech

Founders & leadership

DB
David BrunelExecutive Officer, Director
FR
Frank RonchettiExecutive Officer
JS
Jack SchulerDirector
JP
John PatienceDirector
MS
Matthew StrobeckDirector
MM
Mark MillerDirector
RC
Robert CawthornDirector

Reported raises · per SEC filings

Form D private placements
▶$16MraisedOct 2020 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jean FranchiDirector
  • Hany MassaranyDirector
  • Charles WattsDirector
  • Bobbi CoffinExecutive Officer
  • Gary Pestano, Ph.D.Executive Officer
  • Jim PurvisExecutive Officer
  • Linda Traylor, Ph.D.Executive Officer
  • Paul Beresford, Ph.D.Executive Officer
  • Scott HuttonExecutive Officer, Director
  • Robin CowieExecutive Officer
  • Matthew StrobeckDirector
  • Mark MillerDirector
  • Jack SchulerDirector
  • John PatienceDirector
  • Robert CawthornDirector
  • David BrunelDirector
  • Robert GeorgantasExecutive Officer
Offering amount
$31M
Amount sold
$16M
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedAug 2019 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Linda Traylor, Ph.D.Executive Officer
  • Jim PurvisExecutive Officer
  • Gary Pestano, Ph.D.Executive Officer
  • Bobbi CoffinExecutive Officer
  • Charles WattsDirector
  • Robert GeorgantasExecutive Officer
  • David BrunelExecutive Officer, Director
  • Robert CawthornDirector
  • John PatienceDirector
  • Jack SchulerDirector
  • Mark MillerDirector
  • Matthew StrobeckDirector
  • Robin CowieExecutive Officer
  • Scott HuttonExecutive Officer
  • Paul Beresford, Ph.D.Executive Officer
Offering amount
$10M
Amount sold
$4.9M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.5MraisedOct 2018 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matt StaufferExecutive Officer
  • Mark MillerDirector
  • Matthew StrobeckDirector
  • Robin CowieExecutive Officer
  • Paul Beresford, Ph.D.Executive Officer
  • Bobbi CoffinExecutive Officer
  • Gary Pestano, Ph.D.Executive Officer
  • Jim PurvisExecutive Officer
  • John PatienceDirector
  • Robert CawthornDirector
  • David BrunelExecutive Officer, Director
  • Linda Traylor, Ph.D.Executive Officer
  • Scott HuttonExecutive Officer
  • Heinrich Roder, D.Phil.Executive Officer
  • Jack SchulerDirector
Offering amount
$27.5M
Amount sold
$17.5M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedJul 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack SchulerDirector
  • Mark MillerDirector
  • Paul Beresford, Ph.D.Executive Officer
  • Bobbi CoffinExecutive Officer
  • Matthew StrobeckDirector
  • Robin CowieExecutive Officer
  • John PatienceDirector
  • Linda Traylor, Ph.D.Executive Officer
  • David BrunelExecutive Officer, Director
  • Scott HuttonExecutive Officer
  • Jim PurvisExecutive Officer
  • Robert CawthornDirector
  • Heinrich Roder, D.PhilExecutive Officer
  • Gary Pestano, Ph.D.Executive Officer
Offering amount
$8M
Amount sold
$8M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.3MraisedMay 2018 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack SchulerDirector
  • Paul Beresford, Ph.D.Executive Officer
  • Scott HuttonExecutive Officer
  • Linda Traylor, Ph.D.Executive Officer
  • John PatienceDirector
  • Heinrich Roder, D.Phil.Executive Officer
  • Gary Pestano, Ph.D.Executive Officer
  • Jim PurvisExecutive Officer
  • Bobbi CoffinExecutive Officer
  • David BrunelExecutive Officer, Director
  • Robin CowieExecutive Officer
  • Mark MillerDirector
  • Robert CawthornDirector
  • Matthew StrobeckDirector
Offering amount
$10.3M
Amount sold
$5.3M
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Heinrich Roder, D.Phil.Executive Officer
  • Bobbi CoffinExecutive Officer
  • Jack SchulerDirector
  • Paul Beresford, Ph.D.Executive Officer
  • John PatienceDirector
  • David BrunelExecutive Officer, Director
  • Gary Pestano, Ph.D.Executive Officer
  • Jim PurvisExecutive Officer
  • Robert CawthornDirector
  • Linda Traylor, Ph.D.Executive Officer
  • Matthew StrobeckDirector
  • Scott HuttonExecutive Officer
  • Mark MillerDirector
  • Robin CowieExecutive Officer
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.2MraisedApr 2017 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin CowieExecutive Officer
  • Mark MillerDirector
  • Heinrich Roder, D.Phil.Executive Officer
  • Paul Beresford, Ph.D.Executive Officer
  • Gary Pestano, Ph.D.Executive Officer
  • Wendy BlosserExecutive Officer
  • Jim PurvisExecutive Officer
  • Robert CawthornDirector
  • Jack SchulerDirector
  • Bobbi CoffinExecutive Officer
  • John PatienceDirector
  • Linda Traylor, Ph.D.Executive Officer
  • Liz FliegelmanExecutive Officer
  • Matthew StrobeckDirector
  • David BrunelExecutive Officer, Director
Offering amount
$25.3M
Amount sold
$13.2M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedNov 2016 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John PatienceDirector
  • Jack SchulerDirector
  • David BrunelExecutive Officer, Director
  • Matthew StrobeckDirector
  • Robert CawthornDirector
  • Mark MillerDirector
  • Robin CowieExecutive Officer
Offering amount
$15.7M
Amount sold
$5.1M
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.